Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioalpha Holdings BhdXKLS:0179 -33.33% Equity-to-Asset is 0.90 as of Mar. 2026, which is 5% above its 10-year median of 0.86. The stock has 6 warning signs investors should review. Among 2,006 Consumer Packaged Goods companies, Bioalpha Holdings Bhd ranks better than 95.86% on this metric.
The historical rank and industry rank for Bioalpha Holdings Bhd's Equity-to-Asset or its related term are showing as below:
XKLS:0179'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75 Med: 0.86 Max: 0.91
Current: 0.9
During the past 13 years, the highest Equity to Asset Ratio of Bioalpha Holdings Bhd was 0.91. The lowest was 0.75. And the median was 0.86.
XKLS:0179's Equity-to-Asset is ranked better than 95.86% of 2006
companies
in the Consumer Packaged Goods industry
Industry Median: 0.54
vs XKLS:0179: 0.90
Bioalpha Holdings Bhd (XKLS:0179) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bioalpha Holdings Bhd Equity-to-Asset Related Terms
Bioalpha Holdings Bhd Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Bioalpha Holdings Bhd's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bioalpha Holdings Bhd's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioalpha Holdings Bhd Equity-to-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioalpha Holdings Bhd's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bioalpha Holdings Bhd's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bioalpha Holdings Bhd's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioalpha Holdings Bhd (XKLS:0179) has a Equity-to-Asset of 0.90 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bioalpha Holdings Bhd and its competitors. This is near median its historical median of 0.86. Over the past decade, Bioalpha Holdings Bhd's Equity-to-Asset has ranged from 0.75 to 0.91. According to the industry distribution chart, Bioalpha Holdings Bhd ranks #83 out of 2006 companies in the Consumer Packaged Goods industry, placing it in the top 4.1%.
Is Bioalpha Holdings Bhd's Equity-to-Asset too high?
Bioalpha Holdings Bhd's current Equity-to-Asset of 0.90 is near median its 10-year median of 0.86. Over the past 10 years, this metric has ranged from a low of 0.75 to a high of 0.91. The Consumer Packaged Goods industry median Equity-to-Asset is 0.54. Bioalpha Holdings Bhd's value of 0.90 is 66.7% above this industry median. Based on the distribution chart, Bioalpha Holdings Bhd ranks #83 out of 2006 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers.
How does Bioalpha Holdings Bhd's Equity-to-Asset compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioalpha Holdings Bhd ranks #83 out of 2006 companies for Equity-to-Asset. This places Bioalpha Holdings Bhd in the top 4% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.54. Bioalpha Holdings Bhd's value of 0.90 is 66.7% above this benchmark. Historically, Bioalpha Holdings Bhd's own Equity-to-Asset has ranged from 0.75 to 0.91 over the past decade. While the company's 10-year median is 0.86 vs. the industry median of 0.54, Bioalpha Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Consumer Packaged Goods company?
The median Equity-to-Asset among Consumer Packaged Goods companies is 0.54, based on 2,006 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioalpha Holdings Bhd's current Equity-to-Asset of 0.90 is 66.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bioalpha Holdings Bhd and its competitors. For the Consumer Packaged Goods industry, the median Equity-to-Asset is 0.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioalpha Holdings Bhd's current Equity-to-Asset is 0.90, which is near median its own 10-year median of 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Fairly Valued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.01 — trading right at its estimated fair value. The current Equity-to-Asset is 0.90, which is near median its 10-year median of 0.86 and 66.7% above the Consumer Packaged Goods industry median of 0.54. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current Equity-to-Asset is 0.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0179 has been successfully added to your 
